Accelerating the development of life-changing technologies to bring more care to more patients suffering from stroke and other devastating vascular diseases.
Imperative Care is addressing gaps across the entire patient journey — from detection through recovery — to elevate care for patients suffering from stroke and other devastating vascular diseases.
We know that the future is dependent on the innovations we invest in today.
Without compromising quality, we move swiftly through our development cycle, putting emphasis on testing, clinical evidence, and physician feedback. This strategic agility enables us to react quickly to the needs of physicians and their patients.
Our physician-driven approach to innovation puts the needs, perspectives and ideas of front-line doctors at the center of our research and development process.
From our large, prospective, multicenter Imperative Trial to smaller, single-center studies, we are committed to validating our technologies and solutions with robust clinical data.
Serving stroke survivors has been Kirsten’s life work. She has over 20 years of experience in stroke product development, clinical research, marketing, strategy and business development. Kirsten earned a B.Sc. in biomedical engineering from Yale University and an MBA and MPH from Haas School of Business at UC Berkeley.
Andrew Hack, M.D., Ph.D.
John J. Hamre, Ph.D.
Center for Strategic International Studies
L. Nelson (Nick) Hopkins,
University of Buffalo
D1 Capital Partners L.P
Amarpreet (Amar) Sawhney, Ph.D.
Stacy Enxing Seng
Ally Bridge Group
From day one, Imperative Care has prioritized clinical insights and collaboration with clinicians to inform our approach to elevating stroke care. Our founding clinical advisors have been involved with the company since its inception, and continually help advise on the company’s product pipeline and clinical strategy. The three founding clinical advisors are Adnan Siddiqui, M.D., Ph.D., Neurosurgeon at the University of Buffalo Neurosurgery; Aquilla “Quill” Turk, D.O., Neuroendovascular surgeon in Greenville Health System; and J Mocco, M.D., M.S. Neurosurgeon at the Mount Sinai Health System, New York. All founding clinical advisors are stockholders in Imperative Care.